Senate Health, Education, Labor, and Pensions Committee held the second hearing
in a series on the 340B drug savings program. Shifting away from the first
hearing’s focus on hospitals, the Committee examined program oversight and
questioned delays in implementing a final rule that would set drug ceiling
prices. Many senators noted the benefits of 340B to their states, among others’
continued requests to clarify the program’s intent. Read the full testimonies here.